Neuropharmacology of anxiety: perspectives and prospects.
Hamon
M
M
INSERM U288, Neurobiologie Cellulaire et Fonctionnelle, Faculté de Médecine Pitié-Salpêtrière, Paris, France.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy* / Q000378:metabolism; D004195:Disease Models, Animal; D006801:Humans; D011949:Receptors, Cholecystokinin / Q000187:drug effects / Q000378:metabolism; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism; D013312:Stress, Physiological / Q000378:metabolism
D014151:Anti-Anxiety Agents; D011949:Receptors, Cholecystokinin; D011985:Receptors, Serotonin